Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 406 | 0 | 1,292 | 3,825 |
| Gross Profit | 0 | 406 | N/A | 1,292 | 3,825 |
| Operating Expenses | 53,271 | 43,311 | 44,377 | 40,440 | 15,474 |
| Operating Income | -53,271 | -42,905 | -44,377 | -39,148 | -11,649 |
| Interest Expense | 30,128 | 5,014 | 5,020 | 4,905 | 3,455 |
| Other Income | 6,204 | 2,049 | 3,885 | 4,228 | 7,675 |
| Pre-tax Income | -77,195 | -45,870 | -45,512 | -39,825 | -7,429 |
| Income Tax | -24 | -21 | 40 | -14 | 19,522 |
| Net Income Continuous | -77,171 | -45,849 | -45,552 | -39,811 | -26,951 |
| Net Income | $-77,171 | $-45,849 | $-45,552 | $-39,811 | $-26,951 |
| EPS Basic Total Ops | -0.45 | -0.26 | -0.26 | -0.23 | -0.23 |
| EPS Basic Continuous Ops | -0.44 | -0.26 | -0.26 | -0.23 | -0.23 |
| EPS Diluted Total Ops | -0.45 | -0.26 | -0.26 | -0.23 | -0.23 |
| EPS Diluted Continuous Ops | -0.44 | -0.26 | -0.26 | -0.23 | -0.23 |
| EBITDA(a) | $-51,496 | $-41,526 | $-42,865 | $-37,249 | $-10,000 |